Release Date: 01/02/21 08:09 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 448.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%